Philip Morris
Coverage of Philip Morris in the Nexus archive.
- Win for Zyn nicotine pouches
US regulators allowed Philip Morris to advertise its Zyn nicotine pouches as less harmful than cigarettes, a move that is a marketing win for the company. While tobacco replacements like nicotine pouches and vapes are less deadly than smoking, they remain controversial in public health circles due to concerns over youth vaping and lack of approval as smoking-cessation tools.
- Philip Morris urges EU to treat tobacco like other industries
Philip Morris is urging the EU to treat tobacco like other industries, while health advocates warn that no other legal consumer industry kills more than 700,000 Europeans annually.
- Trump Bought Tobacco Stocks and Raked In Industry Donations as FDA Eased Standards
President Donald Trump held significant stock investments in tobacco companies like Philip Morris and Altria, while tobacco interests donated millions to his political allies. The Trump administration's FDA implemented policies easing regulations on nicotine products and vapes, sparking criticism from public health advocates.
- Philip Morris Cuts Outlook on $500 Million Canada Writedown
Philip Morris has revised its financial outlook due to a $500 million writedown in Canada. The company attributes the adjustment to challenges in the Canadian market.
- Big tobacco is exploiting fears of the illicit market to unwind health gains, Australian experts warn
Big tobacco companies are exploiting fears of the illicit market to unwind health gains, according to Australian experts. A coalition of 15 health organisations has accused the industry of trying to reshape public debate. Cigarettes kill 66 Australians every day.
- Philip Morris uses secret Senate hearing to warn illegal tobacco in Australia could wipe out legal trade by 2030
Tobacco giant Philip Morris warned a secret Senate hearing that illegal tobacco trade in Australia could wipe out legal products by 2030. The company pushed for lower excise and claimed threats from organised crime warranted secrecy. Critics argue Philip Morris has no interest in public health or safety.
- Coalition accused of secretly giving big tobacco lobbyists private platform in parliament
The Coalition is accused of secretly giving big tobacco lobbyists a private platform in parliament, undermining 15 years of public health precedent. A Senate committee heard closed-session evidence from cigarette manufacturers, including Philip Morris. Anti-smoking campaigners are criticizing the move.
- Philip Morris Smoke-Free Shift Gathers Pace as Profit Rises
Philip Morris is accelerating its transition to smoke-free products, with rising profits attributed to this shift. The company's Zyn smokeless nicotine pouch is being sold in New York convenience stores.